Advertisement

Topics

Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

11:44 EDT 21 Aug 2018 | Proactive Investors

Q BioMed Inc (OTCQB: QBIO) CEO Denis Corin tells Proactive Investors the commercial-stage biotech is taking the final step in the approval process of its bone pain relief treatment, the "spearhead'" of Q BioMed's pipeline.

Corin says Q BioMed has submitted a supplemental regulatory filing to the US FDA for the approval of a new manufacturing facility in Texas. Approval will allow the facility to manufacture its Strontium Chloride Sr8 drug.

Cobin says with the approval to manufacture the drug, the company expects to be in the US$2mln to US$3mln revenue point with the opportunity to grow into a US$100mln market in the next few years.

Original Article: Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

NEXT ARTICLE

More From BioPortfolio on "Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...